英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

aeroboat    
n. 水上飞机,飞艇

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • CureVac Appoints Alexander Zehnder as CEO From April 1, 2023
    CureVac Appoints Alexander Zehnder as CEO From April 1, 2023 Dr Franz-Werner Haas to complete successful tenure as CEO by March 31, 2023
  • CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock
    CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock TÜBINGEN, Germany BOSTON, USA – January 17, 2024 – CureVac N V (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that its Chief Executive Officer, Alexander Zehnder, recently purchased
  • CureVac’s CEO Ingmar Hoerr is Keynote Speaker at the Cancer Vaccines . . .
    Ingmar Hoerr is CEO of CureVac, Tuebingen, Germany, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapeutic mRNA vaccines (RNActive ®) for cancer and prophylactic vaccines for infectious diseases as well as adjuvants (RNAdjuvant ®) for enhancing the immune response of other vaccines
  • CureVac Appoints Dr. Franz-Werner Haas as Chief Executive Officer and . . .
    TÜBINGEN, Germany BOSTON, USA – August 4, 2020 – CureVac today announced that Dr Franz-Werner Haas, previously acting Chief Executive Officer and Chief Operating Officer (COO), has been appointed Chief Executive Officer (CEO)
  • CureVac Strengthens Leadership Team with Appointment of Seasoned . . .
    CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer • Experienced CFO and investment banker with 30-year track record will help drive CureVac’s transformation
  • CureVac verstärkt Führungsteam mit Ernennung des erfahrenen . . .
    CureVac verstärkt Führungsteam mit Ernennung des erfahrenen Branchenexperten Axel Sven Malkomes zum Chief Financial Officer • Erfahrener CFO und Investmentbanker mit 30-jähriger Erfolgsbilanz wird Fortschritt von CureVacs Unternehmensentwicklung stärken
  • CureVac Announces Developments in Patent Litigation with Pfizer BioNTech
    “The progress of this litigation to date, in both Europe and the United States, gives us confidence in both the validity of our intellectual property portfolio and its relevance to the mRNA field,” said CureVac CEO Dr Alexander Zehnder “Our scientists have pioneered fundamental break-throughs in mRNA vaccine technology over the last two decades These contributions underpin the rapid
  • CureVacs tailored LNP platforms to deliver mRNA for prophylactic and . . .
    This presentation of CureVac N V and or its wholly owned subsidiaries CureVac SE, CureVac Manufacturing GmbH, CureVac Inc , CureVac Swiss AG, CureVac Corporate Services GmbH, CureVac RNA Printer GmbH, CureVac Belgium SA and CureVac Netherlands B V (the “company”) contains statements that constitute “forward-looking statements” as that term is defined in the United States Private
  • PowerPoint-Präsentation - CureVac
    This presentation of CureVac N V (the “company”) contains statements that constitute “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995, including statements that express the company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections of the company regarding future events or future
  • CureVac Strengthens Ongoing Patent Litigations Bringing Additional . . .
    TÜBINGEN, Germany – July 13, 2023 – CureVac N V (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), today announced that it has strengthened its position in the ongoing patent litigations with Pfizer BioNTech in Germany and





中文字典-英文字典  2005-2009